1. Home
  2. QUAD vs OVID Comparison

QUAD vs OVID Comparison

Compare QUAD & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

HOLD

Current Price

$7.79

Market Cap

383.4M

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.71

Market Cap

365.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
OVID
Founded
1971
2014
Country
United States
United States
Employees
10100
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.4M
365.5M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
QUAD
OVID
Price
$7.79
$2.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.93
$4.60
AVG Volume (30 Days)
171.9K
3.2M
Earning Date
04-28-2026
05-12-2026
Dividend Yield
5.26%
N/A
EPS Growth
150.47
3.90
EPS
0.54
N/A
Revenue
$2,419,900,000.00
$7,252,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$19.34
P/E Ratio
$14.06
N/A
Revenue Growth
N/A
1181.27
52 Week Low
$4.50
$0.27
52 Week High
$7.75
$3.11

Technical Indicators

Market Signals
Indicator
QUAD
OVID
Relative Strength Index (RSI) 74.97 56.90
Support Level $6.38 $1.31
Resistance Level N/A $2.72
Average True Range (ATR) 0.24 0.21
MACD 0.05 -0.02
Stochastic Oscillator 96.12 54.29

Price Performance

Historical Comparison
QUAD
OVID

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: